CAREMARK ADDING $200 MIL. IN HOME INFUSION SALES WITH CRITICAL CARE AMERICA
This article was originally published in The Gray Sheet
Executive SummaryCAREMARK ADDING $200 MIL. IN HOME INFUSION SALES WITH CRITICAL CARE AMERICA acquisition. The $175 mil. cash acquisition was announced as a definitive agreement with CCA parent Medical Care America Jan. 17. Critical Care America's home infusion sales were "over $200 mil." in 1993, the firm said, enough to rank it among the top five home infusion companies. Caremark does not break out the sales of its home infusion operations.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.